Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1984-03-20
1986-02-04
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
A61K 3156
Patent
active
045686734
ABSTRACT:
A compound of the formula ##STR1## wherein Z is alkoxy of 1-4 carbon atoms or hydroxyalkoxy of 2-4 carbon atoms and Y is nitro, inhibiting the growth of murine ductal carcinoma (MXT mammary tumors).
REFERENCES:
patent: 3377362 (1968-04-01), Cantrall et al.
patent: 3526648 (1970-09-01), Bertin et al.
patent: 4340602 (1982-07-01), Brooks
Rozhin et al., Cancer Res., 43:2611-2617, (Jun. 1983).
Rozhin et al., Proc. Am. Assoc. Cancer Res., 21:260, (1980).
Neeman et al., J. Med. Chem., 1983:465-469, (1983).
Utne et al., J. Org. Chem., 33:2469-2473, (1968).
Iyer et al, J. Org. Chem., 47:644, (1982).
Iyer et al, J. Med. Chem., 28:162, (1983).
Brooks et al., J. Toxic. and Environ. Health, 4:283-300, (1978).
Rozhin et al., J. Biol. Chem., 252:7214-7220, (1977).
Pack et al., Endocrinology, 95:1680-1690, (1974).
Brooks Samuel C.
Horwitz Jerome P.
Roberts Elbert L.
Roberts, Jr. John S.
Wayne State University
LandOfFree
Compositions inhibiting murine MXT ductal carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions inhibiting murine MXT ductal carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions inhibiting murine MXT ductal carcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2341019